SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study

Andrew J Pellatt, Roger K Wolff, Esther M John, Gabriela Torres-Mejia, Lisa M Hines, Kathy B Baumgartner, Anna R Giuliano, Abbie Lundgreen, Martha L Slattery, Andrew J Pellatt, Roger K Wolff, Esther M John, Gabriela Torres-Mejia, Lisa M Hines, Kathy B Baumgartner, Anna R Giuliano, Abbie Lundgreen, Martha L Slattery

Abstract

Selenoproteins are a class of proteins containing a selenocysteine residue, many of which have been shown to have redox functions, acting as antioxidants to decrease oxidative stress. Selenoproteins have previously been associated with risk of various cancers and redox-related diseases. In this study we evaluated possible associations between breast cancer risk and survival and single nucleotide polymorphisms (SNPs) in the selenoprotein genes GPX1, GPX2, GPX3, GPX4, SELS, SEP15, SEPN1, SEPP1, SEPW1, TXNRD1, and TXNRD2 among Hispanic/Native American (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1586 controls) women in the Breast Cancer Health Disparities Study. Adaptive Rank Truncated Product (ARTP) analysis was used to determine both gene and pathway significance with these genes. The overall selenoprotein pathway PARTP was not significantly associated with breast cancer risk (PARTP = 0.69), and only one gene, GPX3, was of borderline significance for the overall population (PARTP =0.09) and marginally significant among women with 0-28% Native American (NA) ancestry (PARTP=0.06). The SEPP1 gene was statistically significantly associated with breast cancer risk among women with higher NA ancestry (PARTP=0.002) and contributed to a significant pathway among those women (PARTP=0.04). GPX1, GPX3, and SELS were associated with Estrogen Receptor-/Progesterone Receptor+ status (PARTP = 0.002, 0.05, and 0.01, respectively). Four SNPs (GPX3 rs2070593, rsGPX4 rs2074451, SELS rs9874, and TXNRD1 rs17202060) significantly interacted with dietary oxidative balance score after adjustment for multiple comparisons to alter breast cancer risk. GPX4 was significantly associated with breast cancer survival among those with the highest NA ancestry (PARTP = 0.05) only. Our data suggest that SEPP1 alters breast cancer risk among women with higher levels of NA ancestry.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Ferguson LR, Karunasinghe N (2011) Nutrigenetics, nutrigenomics, and selenium. Front Genet 2: 15 PubMed: .
    1. Gresner P, Gromadzinska J, Jablonska E, Kaczmarski J, Wasowicz W (2009) Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer 65: 34-40. doi:10.1016/j.lungcan.2008.10.023. PubMed: .
    1. Méplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P et al. (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31: 1074-1079. doi:10.1093/carcin/bgq076. PubMed: .
    1. Sutherland A, Kim DH, Relton C, Ahn YO, Hesketh J (2010) Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr 5: 215-223. doi:10.1007/s12263-010-0176-8. PubMed: .
    1. Zhuo P, Goldberg M, Herman L, Lee BS, Wang H et al. (2009) Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res 69: 8183-8190. doi:10.1158/0008-5472.CAN-09-1791. PubMed: .
    1. Takata Y, King IB, Lampe JW, Burk RF, Hill KE et al. (2012) Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans. J Nutr 142: 419-426. doi:10.3945/jn.111.151845. PubMed: .
    1. Irons R, Tsuji PA, Carlson BA, Ouyang P, Yoo MH et al. (2010) Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells. Cancer Prev Res (Phila) 3: 630-639. doi:10.1158/1940-6207.CAPR-10-0003.
    1. Moghadaszadeh B, Beggs AH (2006) Selenoproteins and their impact on human health through diverse physiological pathways. Physiology (Bethesda) 21: 307-315. doi:10.1152/physiol.00021.2006. PubMed: .
    1. Cheng Q, Sandalova T, Lindqvist Y, Arnér ES (2009) Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1. J Biol Chem 284: 3998-4008. PubMed: .
    1. Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9: 775-806. doi:10.1089/ars.2007.1528. PubMed: .
    1. Ganther HE (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20: 1657-1666. doi:10.1093/carcin/20.9.1657. PubMed: .
    1. Zhu X, Huang C, Peng B (2011) Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol 47: 609-614. doi:10.1016/j.oraloncology.2011.05.006. PubMed: .
    1. Zhuo P, Diamond AM (2009) Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 1790: 1546-1554. doi:10.1016/j.bbagen.2009.03.004. PubMed: .
    1. Ravn-Haren G, Olsen A, Tjønneland A, Dragsted LO, Nexø BA et al. (2006) Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27: 820-825. PubMed: .
    1. Arbogast S, Beuvin M, Fraysse B, Zhou H, Muntoni F et al. (2009) Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment. Ann Neurol 65: 677-686. doi:10.1002/ana.21644. PubMed: .
    1. Pellatt AJ, Wolff RK, Torres-Mejia G, John EM, Herrick JS et al. (2013) Telomere length, telomere-related genes, and breast cancer risk: The breast cancer health disparities study. Genes Chromosomes Cancer 52: 595-609. PubMed: .
    1. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS et al. (2012) Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 33: 1512-1521. doi:10.1093/carcin/bgs163. PubMed: .
    1. Vogt TM, Ziegler RG, Patterson BH, Graubard BI (2007) Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 166: 280-288. doi:10.1093/aje/kwm075. PubMed: .
    1. Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K et al. (2007) Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102: 85-101. doi:10.1007/s10549-006-9292-y. PubMed: .
    1. John EM, Horn-Ross PL, Koo J (2003) Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 12: 1143-1152. PubMed: .
    1. John EM, Phipps AI, Davis A, Koo J (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14: 2905-2913. doi:10.1158/1055-9965.EPI-05-0483. PubMed: .
    1. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP et al. (2013) Angiogenesis genes, dietary oxidative balance, and breast cancer risk and progression: The breast cancer health disparities study. Int J Cancer.
    1. Falush D, Stephens M, Pritchard JK (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164: 1567-1587. PubMed: .
    1. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959. PubMed: .
    1. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769. doi:10.1086/383251. PubMed: .
    1. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95: 221-227. doi:10.1038/sj.hdy.6800717. PubMed: .
    1. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS et al. (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33: 700-709. doi:10.1002/gepi.20422. PubMed: .
    1. Kai Yu OL, Wheeler W (2011). ARTP Gene and Pathway p-values computed using the Adaptive Rank Truncated Product. 2.0.0 ed. pp. R package
    1. Takata Y, Kristal AR, Santella RM, King IB, Duggan DJ et al. (2012) Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants. PLOS ONE 7: e38612. doi:10.1371/journal.pone.0038612. PubMed: .
    1. Hu YJ, Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63: 3347-3351. PubMed: .
    1. Behne D, Kyriakopoulos A (2001) Mammalian selenium-containing proteins. Annu Rev Nutr 21: 453-473. doi:10.1146/annurev.nutr.21.1.453. PubMed: .
    1. Hu J, Zhou GW, Wang N, Wang YJ (2010) GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124: 425-431. doi:10.1007/s10549-010-0841-z. PubMed: .
    1. Cox DG, Hankinson SE, Kraft P, Hunter DJ (2004) No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13: 1821-1822. PubMed: .
    1. Meplan C, Dragsted LO, Ravn-Haren G, Tjonneland A, Vogel U et al. (2013) Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk. PLOS ONE 8: e73316. doi:10.1371/journal.pone.0073316.
    1. Penney KL, Li H, Mucci LA, Loda M, Sesso HD et al. (2013) Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival. Prostate 73: 700-705. doi:10.1002/pros.22611. PubMed: .
    1. Geybels MS, Hutter CM, Kwon EM, Ostrander EA, Fu R et al. (2013) Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate 73: 734-742. doi:10.1002/pros.22617. PubMed: .
    1. Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y et al. (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 17: 1144-1154. doi:10.1158/1055-9965.EPI-07-2947. PubMed: .
    1. Gentschew L, Bishop KS, Han DY, Morgan AR, Fraser AG et al. (2012) Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand. Nutrients 4: 1247-1259. doi:10.3390/nu4091247. PubMed: .
    1. Zhou X, Smith AM, Failla ML, Hill KE, Yu Z (2012) Estrogen status alters tissue distribution and metabolism of selenium in female rats. J Nutr Biochem 23: 532-538. doi:10.1016/j.jnutbio.2011.02.008. PubMed: .
    1. Karunasinghe N, Han DY, Zhu S, Yu J, Lange K et al. (2012) Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr 7: 179-190. doi:10.1007/s12263-011-0259-1. PubMed: .
    1. Jardim BV, Moschetta MG, Leonel C, Gelaleti GB, Regiani VR et al. (2013) Glutathione and glutathione peroxidase expression in breast cancer: An immunohistochemical and molecular study. Oncol Rep 30: 1119–1128. PubMed: .
    1. Udler M, Maia AT, Cebrian A, Brown C, Greenberg D et al. (2007) Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. J Clin Oncol 25: 3015-3023. doi:10.1200/JCO.2006.10.0099. PubMed: .
    1. Damdimopoulos AE, Miranda-Vizuete A, Treuter E, Gustafsson JA, Spyrou G (2004) An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J Biol Chem 279: 38721-38729. doi:10.1074/jbc.M402753200. PubMed: .
    1. Chua PJ, Yip GW, Bay BH (2009) Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells. Exp Biol Med (Maywood) 234: 1086-1094. doi:10.3181/0903-RM-98. PubMed: .
    1. Chen YC, Prabhu KS, Mastro AM (2013) Is selenium a potential treatment for cancer metastasis? Nutrients 5: 1149-1168. doi:10.3390/nu5041149. PubMed: .
    1. Rayman MP (2009) Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 1790: 1533-1540. doi:10.1016/j.bbagen.2009.03.014. PubMed: .
    1. Méplan C, Hesketh J (2012) The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis 27: 177-186. doi:10.1093/mutage/ger058. PubMed: .
    1. Steinbrecher A, Méplan C, Hesketh J, Schomburg L, Endermann T et al. (2010) Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 19: 2958-2968. doi:10.1158/1055-9965.EPI-10-0364. PubMed: .
    1. Gautrey H, Nicol F, Sneddon AA, Hall J, Hesketh J (2011) A T/C polymorphism in the GPX4 3'UTR affects the selenoprotein expression pattern and cell viability in transfected Caco-2 cells. Biochim Biophys Acta 1810: 584-591. PubMed: .
    1. Edvardsen H, Landmark-Høyvik H, Reinertsen KV, Zhao X, Grenaker-Alnaes GI et al. (2013) SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling. Int J Radiat Oncol Biol Phys 86: 791-799. doi:10.1016/j.ijrobp.2013.02.025. PubMed: .

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa